F. Vögtle and E. Weber, Octopus Molecules, Angewandte Chemie International Edition in English, vol.6, issue.12, pp.814-816, 1974.
DOI : 10.1107/S0365110X65002086

E. Buhleier, W. Wehner, and F. Vögtle, "Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies, Synthesis, vol.1978, issue.02, pp.155-158, 1978.
DOI : 10.1055/s-1978-24702

D. A. Tomalia, H. Baker, J. Dewald, M. Hall, G. Kallos et al., Dendritic macromolecules: synthesis of starburst dendrimers, Macromolecules, vol.19, issue.9, pp.2466-2468, 1986.
DOI : 10.1021/ma00163a029

J. Lim, M. Kostiainen, J. Maly, V. C. Da-costa, O. Annunziata et al., Synthesis of Large Dendrimers with the Dimensions of Small Viruses, Journal of the American Chemical Society, vol.135, issue.12, pp.4660-4663, 2013.
DOI : 10.1021/ja400432e

C. T. Varner, T. Rosen, J. T. Martin, and R. S. Kane, Recent Advances in Engineering Polyvalent Biological Interactions, Biomacromolecules, vol.16, issue.1, pp.43-55, 2015.
DOI : 10.1021/bm5014469

N. Jayaraman, Multivalent ligand presentation as a central concept to study intricate carbohydrate???protein interactions, Chemical Society Reviews, vol.8, issue.12, pp.3463-3483, 2009.
DOI : 10.1002/(SICI)1099-0690(199809)1998:9<1879::AID-EJOC1879>3.0.CO;2-8

M. Mammen, S. K. Choi, and G. M. Whitesides, Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors, Angewandte Chemie International Edition, vol.37, issue.20, pp.2754-2794, 1998.
DOI : 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3

J. E. Gestwicki, C. W. Cairo, L. E. Strong, K. A. Oetjen, and L. L. Kiessling, Influencing Receptor???Ligand Binding Mechanisms with Multivalent Ligand Architecture, Journal of the American Chemical Society, vol.124, issue.50, pp.14922-14933, 2002.
DOI : 10.1021/ja027184x

V. L. Colvin, The potential environmental impact of engineered nanomaterials, Nature Biotechnology, vol.21, issue.10, pp.1166-1170, 2003.
DOI : 10.1038/nbt875

P. Hoet, B. Legiest, J. Geys, and B. Nemery, Do nanomedicines require novel safety assessments to ensure their safety for long-term human use? Drug Saf, pp.625-636, 2009.

M. A. Hamburg, FDA's Approach to Regulation of Products of Nanotechnology, Science, vol.61, issue.6, pp.299-300
DOI : 10.1016/j.addr.2009.03.006

F. Ehmann, K. Sakai-kato, R. Duncan, D. Hernán-pérez-de-la-ossa, R. Pita et al., Next-generation nanomedicines and nanosimilars: EU regulators??? initiatives relating to the development and evaluation of nanomedicines, Nanomedicine, vol.3, issue.5, pp.849-856, 2013.
DOI : 10.1007/s11095-010-0233-4

R. Pita, F. Ehmann, and M. Papaluca, Nanomedicines in the EU???Regulatory Overview, The AAPS Journal, vol.18, issue.6, pp.1576-1582
DOI : 10.1208/s12248-016-9967-1

. Nanomedicine-initiative and . Project, Available online: http://www.pmda.go.jp/english/rs-sb-std/standards- development/cross-sectional-project/0008, 2017.

D. Astruc, E. Boisselier, and C. Ornelas, Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine, Chemical Reviews, vol.110, issue.4, pp.1857-1959, 2010.
DOI : 10.1021/cr900327d

R. M. Kannan, E. Nance, S. Kannan, and D. A. Tomalia, Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications, Journal of Internal Medicine, vol.5, issue.6, pp.579-617, 2014.
DOI : 10.1021/nn2038252

C. C. Lee, J. A. Mackay, J. M. Fréchet, and F. C. Szoka, Designing dendrimers for biological applications, Nature Biotechnology, vol.124, issue.12, pp.1517-1526, 2005.
DOI : 10.1007/3-540-12796-8_9

X. Liu and L. Peng, Dendrimer Nanovectors for SiRNA Delivery, Methods Mol. Biol, vol.2016, issue.1364, pp.127-142
DOI : 10.1007/978-1-4939-3112-5_11

A. R. Menjoge, R. M. Kannan, and D. A. Tomalia, Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications, Drug Discovery Today, vol.15, issue.5-6, pp.171-185, 2010.
DOI : 10.1016/j.drudis.2010.01.009

S. Shaunak and . Perspective, Dendrimer drugs for infection and inflammation, Biochem. Biophys. Res. Commun, vol.2015, issue.468, pp.435-441

R. Duncan and S. Patterson, Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation, Nat. Biotechnol, vol.8, pp.977-984, 2004.

I. Teo, S. M. Toms, B. Marteyn, T. S. Barata, P. Simpson et al., Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers, EMBO Molecular Medicine, vol.64, issue.9, pp.866-881, 2012.
DOI : 10.1074/jbc.M112.343467

T. S. Barata, S. Shaunak, I. Teo, M. Zloh, and S. Brocchini, Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers, Journal of Molecular Modeling, vol.42, issue.8, pp.2051-2060, 2011.
DOI : 10.1021/ma802154e

URL : https://hal.archives-ouvertes.fr/hal-00652151

T. S. Barata, I. Teo, S. Lalwani, E. Simanek, M. Zloh et al., Computational design principles for bioactive dendrimer based constructs as antagonists of the TLR4-MD-2-LPS complex, Biomaterials, vol.32, issue.33, pp.8702-8711, 2011.
DOI : 10.1016/j.biomaterials.2011.07.085

T. S. Barata, I. Teo, S. Brocchini, M. Zloh, and S. Shaunak, Partially Glycosylated Dendrimers Block MD-2 and Prevent TLR4-MD-2-LPS Complex Mediated Cytokine Responses, PLoS Computational Biology, vol.457, issue.9, 2011.
DOI : 10.1371/journal.pcbi.1002095.s007

D. Islam, E. Lombardini, N. Ruamsap, R. Imerbsin, P. Khantapura et al., Controlling the cytokine storm in severe bacterial diarrhoea with an oral Toll-like receptor 4 antagonist, Immunology, vol.11, issue.2, pp.178-189, 2015.
DOI : 10.1016/j.nano.2015.02.018

A. S. Chauhan, P. V. Diwan, N. K. Jain, and D. A. Tomalia, Unexpected In Vivo Anti-Inflammatory Activity Observed for Simple, Surface Functionalized Poly(amidoamine) Dendrimers, Biomacromolecules, vol.10, issue.5, pp.1195-1202, 2009.
DOI : 10.1021/bm9000298

Y. Tang, Y. Han, L. Liu, W. Shen, H. Zhang et al., Protective Effects and Mechanisms of G5 PAMAM Dendrimers against Acute Pancreatitis Induced by Caerulein in Mice, Biomacromolecules, vol.16, issue.1, pp.174-182, 2015.
DOI : 10.1021/bm501390d

S. M. Rele, W. Cui, L. Wang, S. Hou, G. Barr-zarse et al., Dendrimer-like PEO Glycopolymers Exhibit Anti-Inflammatory Properties, Journal of the American Chemical Society, vol.127, issue.29, pp.10132-10133, 2005.
DOI : 10.1021/ja0511974

URL : https://hal.archives-ouvertes.fr/hal-00394336

R. Haag, Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation, Proc. Natl. Acad. Sci. USA 2010, pp.19679-19684

J. Ledall, S. Fruchon, M. Garzoni, G. M. Pavan, A. M. Caminade et al., Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes, Nanoscale, vol.10, issue.42, pp.17672-17684, 2015.
DOI : 10.1021/bm9000298

S. Fruchon, M. Poupot, L. Martinet, C. O. Turrin, J. P. Majoral et al., Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer, Journal of Leukocyte Biology, vol.85, issue.3, pp.553-562, 2009.
DOI : 10.1189/jlb.0608371

O. Rolland, C. O. Turrin, G. Bacquet, R. Poupot, M. Poupot et al., Efficient synthesis of phosphorus-containing dendrimers capped with isosteric functions of amino-bismethylene phosphonic acids, Tetrahedron Letters, vol.50, issue.18, pp.2078-2082, 2009.
DOI : 10.1016/j.tetlet.2009.02.127

A. M. Caminade, S. Fruchon, C. O. Turrin, M. Poupot, A. Ouali et al., The key role of the scaffold on the efficiency of dendrimer nanodrugs, Nature Communications, vol.79, pp.2015-7722
DOI : 10.1063/1.445869

M. Hayder, M. Poupot, M. Baron, D. Nigon, C. O. Turrin et al., Cantagrel, A.; et al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis, Sci. Transl. Med, vol.3, pp.81-116, 2011.

M. Hayder, M. Poupot, M. Baron, C. O. Turrin, A. M. Caminade et al., Poupot, R.; et al. Frequency and route of administration in the treatment of experimental arthritis by phosphorus-based dendrimer, Ann. Rheum. Dis, p.71, 2012.

M. Hayder, M. Varilh, C. O. Turrin, A. Saoudi, A. M. Caminade et al., T Cells, Biomacromolecules, vol.16, issue.11, pp.3425-3433, 2015.
DOI : 10.1021/acs.biomac.5b00643

Y. Degboé, S. Fruchon, M. Baron, D. Nigon, C. O. Turrin et al., Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent, Arthritis Research & Therapy, vol.16, issue.2, p.98, 2014.
DOI : 10.1038/ni1254

D. Portevin, M. Poupot, O. Rolland, C. O. Turrin, J. J. Fournié et al., Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy, Journal of Translational Medicine, vol.7, issue.1, p.82, 2009.
DOI : 10.1186/1479-5876-7-82

URL : https://hal.archives-ouvertes.fr/inserm-00668486

S. Fruchon, A. M. Caminade, C. Abadie, J. L. Davignon, J. M. Combette et al., An Azabisphosphonate-Capped Poly(phosphorhydrazone) Dendrimer for the Treatment of Endotoxin-Induced Uveitis, Molecules, vol.133, issue.8, pp.9305-9316, 2013.
DOI : 10.1186/1479-5876-7-82

E. Blattes, A. Vercellone, H. Eutamène, C. O. Turrin, V. Théodorou et al., Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment, Proc. Natl. Acad. Sci. USA 2013, pp.8795-8800
DOI : 10.1016/j.tetlet.2009.02.127

URL : https://hal.archives-ouvertes.fr/hal-00994589

I. Durocher and D. Girard, In vivo proinflammatory activity of generations 0???3 (G0???G3) polyamidoamine (PAMAM) nanoparticles, Inflammation Research, vol.9, issue.9, pp.745-755, 2016.
DOI : 10.1016/j.nano.2012.05.002

URL : https://hal.archives-ouvertes.fr/pasteur-01351122

S. Fruchon, S. Mouriot, T. Thiollier, C. Grandin, A. M. Caminade et al., Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer, Nanotoxicology, vol.7, issue.4, pp.933-941
DOI : 10.1538/expanim.49.97

M. A. Dobrovolskaia, D. R. Germolec, and J. L. Weaver, Evaluation of nanoparticle immunotoxicity, Nature Nanotechnology, vol.173, issue.7, pp.411-414, 2009.
DOI : 10.4049/jimmunol.173.5.3148

A. N. Ilinskaya and M. A. Dobrovolskaia, Immunosuppressive and anti-inflammatory properties of engineered nanomaterials, Br. J. Pharmacol, vol.2014, issue.171, pp.3988-4000